Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eriko Hosomi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurochemical Research|July 15, 2020
The Combination of Cholecystokinin and Stress Amplifies an Inhibition of Appetite, Gastric Emptying, and an Increase in c-Fos Expression in Neurons of the Hypothalamus and the Medulla OblongataNaomi Yamaguchi, Eriko Hosomi, Yutaro Hori, et al.
Current Therapeutic Research, Clinical and Experimental|September 16, 2017
Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot StudyKoji Yakabi, Naomi Yamaguchi, Shino Ono, et al.
Neurogastroenterology and Motility|August 21, 2024
Rikkunshito improves anorexia through ghrelin- and orexin-dependent activation of the brain hypothalamus and mesolimbic dopaminergic pathway in ratsKoji Yakabi, Naomi Yamaguchi, Kiyoshige Takayama, et al.
Journal of Crohn'S & Colitis|March 6, 2012
The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscessesShingo Kato, Eriko Hosomi, Fumi Amano, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurochemical Research|July 15, 2020
The Combination of Cholecystokinin and Stress Amplifies an Inhibition of Appetite, Gastric Emptying, and an Increase in c-Fos Expression in Neurons of the Hypothalamus and the Medulla OblongataNaomi Yamaguchi, Eriko Hosomi, Yutaro Hori, et al.
Current Therapeutic Research, Clinical and Experimental|September 16, 2017
Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot StudyKoji Yakabi, Naomi Yamaguchi, Shino Ono, et al.
Neurogastroenterology and Motility|August 21, 2024
Rikkunshito improves anorexia through ghrelin- and orexin-dependent activation of the brain hypothalamus and mesolimbic dopaminergic pathway in ratsKoji Yakabi, Naomi Yamaguchi, Kiyoshige Takayama, et al.
Journal of Crohn'S & Colitis|March 6, 2012
The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscessesShingo Kato, Eriko Hosomi, Fumi Amano, et al.
Pageof 1